Targeting JAK1/STAT3 signaling suppresses tumor progression and metastasis in a peritoneal model of human ovarian cancer
about
Targeted Blockade of JAK/STAT3 Signaling Inhibits Ovarian Carcinoma Growth.Synergistic anti-tumor effect of combined inhibition of EGFR and JAK/STAT3 pathways in human ovarian cancer.Lycorine is a novel inhibitor of the growth and metastasis of hormone-refractory prostate cancer.STAT3 in the systemic inflammation of cancer cachexia.Onionin A inhibits ovarian cancer progression by suppressing cancer cell proliferation and the protumour function of macrophagesInvestigational therapies targeting signal transducer and activator of transcription 3 for the treatment of cancer.Emerging cytokine networks in colorectal cancer.Jak1-STAT3 Signals Are Essential Effectors of the USP6/TRE17 Oncogene in Tumorigenesis.Apatinib promotes autophagy and apoptosis through VEGFR2/STAT3/BCL-2 signaling in osteosarcoma.Elevated STAT3 expression in ovarian cancer ascites promotes invasion and metastasis: a potential therapeutic target.STAT3 inhibition reduces toxicity of oncolytic VSV and provides a potentially synergistic combination therapy for hepatocellular carcinoma.Pterostilbene, a natural phenolic compound, synergizes the antineoplastic effects of megestrol acetate in endometrial cancer.Collagen triple helix repeat containing 1 (CTHRC1) activates Integrin β3/FAK signaling and promotes metastasis in ovarian cancer.Physapubescin B inhibits tumorgenesis and circumvents taxol resistance of ovarian cancer cells through STAT3 signaling.Relationship between HER2 and JAK/STAT-SOCS3 signaling pathway and clinicopathological features and prognosis of ovarian cancer.ATM‑JAK‑PD‑L1 signaling pathway inhibition decreases EMT and metastasis of androgen‑independent prostate cancer.Akt2/ZEB2 may be a biomarker for exfoliant cells in ascitic fluid in advanced grades of serous ovarian carcinoma.Ruxolitinib synergistically enhances the anti-tumor activity of paclitaxel in human ovarian cancer.
P2860
Q35374753-63EF5216-F2DB-4993-BAE3-CB1C02CDE7CEQ35619189-C167E705-A1E6-490C-95FA-4E8AC4522DAFQ36021024-E350ADF9-2455-4EE4-BE53-F59A4E02F580Q36901910-DFA39AD2-CFD9-48CC-915A-5C09AB0A8A28Q37087247-4ADD9E34-1623-4B2D-BF95-DB8B68456B2AQ38369000-3CFCB91F-A84C-44DF-BE39-2C3BAA56ED44Q38584430-BBDAE09E-7CC2-4941-97F9-B0E78FC9316FQ38756741-AA7E1B38-CD0B-4B26-8164-DDD67CE76EEDQ41167283-42B93A4B-3366-443E-8DEB-08CE230AAFCEQ41863613-E4689517-83A3-4A39-9D03-70A3221B92F7Q42144822-4116A9F3-3192-434F-97F0-6A554911F8F0Q42371820-5AFDD9E6-4149-467F-A5EE-9B5F893DF658Q42375241-9BF99359-BA45-47A6-92C5-2E52A897CC1CQ42378411-660B67BF-4DC3-4002-9A2D-DA3EA06AB324Q50696151-594CFBAA-6743-4CA8-AB5F-0C63985DDA57Q52641296-3B294A22-E930-421D-B431-5EEE222C979DQ53536514-B847CFA3-6C2C-467D-9E92-50B2AA1DD309Q55084775-B4A4A828-5808-45CD-A568-0388A442D2C6
P2860
Targeting JAK1/STAT3 signaling suppresses tumor progression and metastasis in a peritoneal model of human ovarian cancer
description
2014 nî lūn-bûn
@nan
2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Targeting JAK1/STAT3 signaling ...... model of human ovarian cancer
@ast
Targeting JAK1/STAT3 signaling ...... model of human ovarian cancer
@en
type
label
Targeting JAK1/STAT3 signaling ...... model of human ovarian cancer
@ast
Targeting JAK1/STAT3 signaling ...... model of human ovarian cancer
@en
prefLabel
Targeting JAK1/STAT3 signaling ...... model of human ovarian cancer
@ast
Targeting JAK1/STAT3 signaling ...... model of human ovarian cancer
@en
P2093
P2860
P1476
Targeting JAK1/STAT3 signaling ...... model of human ovarian cancer
@en
P2093
Anna Scuto
Christine E Brown
Claudia M Kowolik
David Horne
Ernest S Han
John H Yim
Mark Wakabayashi
Meng-Yin Hsieh
P2860
P304
P356
10.1158/1535-7163.MCT-14-0077
P577
2014-10-15T00:00:00Z